These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
156 related items for PubMed ID: 26991068
1. Tectorigenin inhibits osteosarcoma cell migration through downregulation of matrix metalloproteinases in vitro. Guo Y, Chen YH, Cheng ZH, Ou-Yang HN, Luo C, Guo ZL. Anticancer Drugs; 2016 Jul; 27(6):540-6. PubMed ID: 26991068 [Abstract] [Full Text] [Related]
3. Tetramethylpyrazine inhibits osteosarcoma cell proliferation via downregulation of NF-κB in vitro and in vivo. Wang Y, Fu Q, Zhao W. Mol Med Rep; 2013 Oct; 8(4):984-8. PubMed ID: 23912183 [Abstract] [Full Text] [Related]
5. Bufalin-inhibited migration and invasion in human osteosarcoma U-2 OS cells is carried out by suppression of the matrix metalloproteinase-2, ERK, and JNK signaling pathways. Chueh FS, Chen YY, Huang AC, Ho HC, Liao CL, Yang JS, Kuo CL, Chung JG. Environ Toxicol; 2014 Jan; 29(1):21-9. PubMed ID: 21922632 [Abstract] [Full Text] [Related]
8. Paris saponin VII suppresses osteosarcoma cell migration and invasion by inhibiting MMP‑2/9 production via the p38 MAPK signaling pathway. Cheng G, Gao F, Sun X, Bi H, Zhu Y. Mol Med Rep; 2016 Oct; 14(4):3199-205. PubMed ID: 27572907 [Abstract] [Full Text] [Related]
10. MicroRNA-129-5p suppresses cell proliferation, migration and invasion via targeting ROCK1 in osteosarcoma. Han C, Wang W. Mol Med Rep; 2018 Mar; 17(3):4777-4784. PubMed ID: 29328417 [Abstract] [Full Text] [Related]
12. MicroRNA‑22 inhibits the proliferation and migration, and increases the cisplatin sensitivity, of osteosarcoma cells. Zhou X, Natino D, Zhai X, Gao Z, He X. Mol Med Rep; 2018 May; 17(5):7209-7217. PubMed ID: 29568877 [Abstract] [Full Text] [Related]
13. Theabrownin inhibits the cytoskeleton‑dependent cell cycle, migration and invasion of human osteosarcoma cells through NF‑κB pathway‑related mechanisms. Jin W, Gu C, Zhou L, Yang X, Gui M, Zhang J, Chen J, Dong X, Yuan Q, Shan L. Oncol Rep; 2020 Dec; 44(6):2621-2633. PubMed ID: 33125106 [Abstract] [Full Text] [Related]
14. Inositol polyphosphate-4-phosphatase type II and rucaparib treatment inhibit the growth of osteosarcoma cells dependent on phosphoinositide 3-kinase/protein kinase B pathway. Li D, Yang J, Ma H, Sun C, Feng R. J Cell Biochem; 2018 Dec; 119(12):9899-9909. PubMed ID: 30132953 [Abstract] [Full Text] [Related]
15. MicroRNA-1253 Suppresses Cell Proliferation Migration and Invasion of Osteosarcoma by Targeting MMP9. Mo J, Zheng T, Lei L, Dai P, Liu J, He H, Shi J, Chen X, Guo T, Yuan B, Ji G. Technol Cancer Res Treat; 2021 Dec; 20():1533033821995278. PubMed ID: 34036868 [Abstract] [Full Text] [Related]
16. Clinical case report of patients with osteosarcoma and anticancer benefit of calycosin against human osteosarcoma cells. Qiu R, Ma G, Li X, Shi Q, Li X, Zhou X, Tang Y, Xie Z, Liao S, Qin Y, Wang R, Ye Y, Luo J, Zhang J. J Cell Biochem; 2019 Jun; 120(6):10697-10706. PubMed ID: 30652346 [Abstract] [Full Text] [Related]
17. Kaempferol suppresses cell metastasis via inhibition of the ERK-p38-JNK and AP-1 signaling pathways in U-2 OS human osteosarcoma cells. Chen HJ, Lin CM, Lee CY, Shih NC, Peng SF, Tsuzuki M, Amagaya S, Huang WW, Yang JS. Oncol Rep; 2013 Aug; 30(2):925-32. PubMed ID: 23708932 [Abstract] [Full Text] [Related]
19. Antimetastatic effects of calycosin on osteosarcoma and the underlying mechanism. Qiu R, Li X, Qin K, Chen X, Wang R, Dai Y, Deng L, Ye Y. Biofactors; 2019 Nov; 45(6):975-982. PubMed ID: 31322783 [Abstract] [Full Text] [Related]
20. miR-1301/TRIAP1 Axis Participates in Epirubicin-Mediated Anti-Proliferation and Pro-Apoptosis in Osteosarcoma. Yu L, Meng M, Bao Y, Zhang C, Gao B, Sa R, Luo W. Yonsei Med J; 2019 Sep; 60(9):832-841. PubMed ID: 31433581 [Abstract] [Full Text] [Related] Page: [Next] [New Search]